Share on LinkedInShare on LinkedIn

ARTICLE · 09 JANUARY 2026

Impact Of DPDP Act And Rules On Pharmaceutical Companies

This Article examines the impact of the Digital Personal Data Protection Act, 2023 ("DPDP Act/Act") on pharmaceutical companies in so far as the collection, processing...

IndiaPrivacy

This Article examines the impact of the Digital Personal Data Protection Act, 2023 ("DPDP Act/Act") on pharmaceutical companies in so far as the collection, processing, storage and sharing of personal and sensitive health data is concerned. While the Act strengthens a patient's privacy, and data protection, it also poses operational, legal and financial challenges, especially for multinational players handling cross-border data transfers and legacy data systems.

INTRODUCTION

On 13th November, 2025, the Ministry of Electronics and Information Technology notified the Digital Personal Data Protection Rules, 2025 ("Rules"). The Rules impose strict regulations regarding how the organizations should collect, store, process, transfer and safeguard the personal data of individuals. The implementation of these Rules has directly impacted several healthcare stakeholders, including hospitals, pharmaceutical companies and digital health platforms since the core activities

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from